Original contribution
Doppler Estimation of Reduced Coronary Flow Reserve in Mice with Pressure Overload Cardiac Hypertrophy

https://doi.org/10.1016/j.ultrasmedbio.2007.11.019Get rights and content

Abstract

Aortic banding produces pressure overload cardiac hypertrophy in mice, leading to decompensated heart failure in four to eight weeks, but the effects on coronary blood flow velocity and reserve are unknown. To determine whether coronary flow reserve (CFR) was reduced, we used noninvasive 20-MHz Doppler ultrasound to measure left main coronary flow velocity at baseline (B) and at hyperemia (H) induced by low (1%) and high (2.5%) concentrations of isoflurane gas anesthesia. Ten mice were studied before (Pre) and at 1 d, 7 d, 14 d and 21 d after constricting the aortic arch to 0.4 mm diameter distal to the innominate artery. We also measured cardiac inflow and outflow velocities at the mitral and aortic valves and velocity at the jet distal to the aortic constriction. The pressure drop as estimated by 4V2 at the jet was 51 ± 5.1 (mean ± SE) mm Hg at 1 d, increasing progressively to 74 ± 5.2 mm Hg at 21 d. Aortic and mitral blood velocities were not significantly different after banding (p = NS), but CFR, as estimated by H/B, dropped progressively from 3.2 ± 0.3 before banding to 2.2 ± 0.4, 1.7 ± 0.3, 1.4 ± 0.2 and 1.1 ± 0.1 at 1 d, 7 d, 14 d and 21 d, respectively (all p < 0.01 vs. Pre). There was also a significant and progressive increase the systolic/diastolic velocity ratio (0.17 Pre to 0.92 at 21 d, all p < 0.01 vs. Pre) suggesting a redistribution of perfusion from subendocardium to subepicardium. We show for the first time that CFR, as estimated by the hyperemic response to isoflurane and measured by Doppler ultrasound, can be measured serially in mice and conclude that CFR is virtually eliminated in banded mice after 21 d of remodeling and hypertrophy. These results demonstrate that CFR is reduced in mice as in humans with cardiac disease but before the onset of decompensated heart failure. (E-mail: [email protected])

Introduction

Coronary flow is often normal at rest, even in the presence of significant coronary lesions, but maximum flow during exercise or stress can be decreased (Gould et al. 1974). Coronary flow reserve (CFR) is defined as the ratio of maximal-hyperemic/baseline-resting flow or velocity and is often used as an index of the functional severity of coronary stenoses seen angiographically (Cole and Hartley 1977, White et al 1984). Coronary flow reserve is also reduced in the presence of valvular and other forms of heart and vascular diseases, which increase loading conditions and produce cardiac hypertrophy (Fallen et al 1967, Marcus et al 1982, Marcus 1983, Santagata et al 2005, Neishi et al 2005, Parrish et al 1985). The mechanism for this reduction is thought to be caused by increases in resting baseline coronary flow as a result of increased cardiac work (Marcus et al 1982, Eberli et al 1989, Parrish et al 1985, Bache et al 1987). Because oxygen delivery and cardiac work are closely related, the magnitude of CFR is similar to that of cardiac reserve (the ratio of maximal/baseline cardiac output) in normal individuals, and both CFR and exercise capacity tend to be reduced by similar amounts in the presence of cardiovascular disease (Rushmer 1976). It is thought that decompensated heart failure ensues only after cardiac and coronary reserves are exhausted (Rushmer 1976, Fallen et al 1967, Vatner and Hittinger 1993, Hittinger et al 1989). Now that mice are being used as cardiovascular disease models (Niebauer et al 1999, Rockman et al 1993, Brickson et al 2006, Barrick et al 2007, Tanaka et al 1996, Maslov et al 2007), it is important to determine if the changes in myocardial perfusion and reserve in the face of increased loading conditions are similar in mice, humans and larger mammals.

We have recently developed a noninvasive method to measure coronary flow velocity in mice using Doppler ultrasound and have shown that isoflurane gas can be used as a convenient coronary vasodilator when the concentration is increased from 1 to 2.5% (Hartley et al. 2007). We used the ratio of hyperemic/baseline (H/B) left main coronary velocity as an index of CFR, and showed that H/B was a function of age and was reduced in 2-year-old apolipoprotein-E null (ApoE-/-) mice when compared with age-matched controls as shown in Fig. 1. The increased flow velocity at baseline and during hyperemia in the ApoE-/- mice is consistent with the presence of coronary lesions in some of the mice. Others have shown that cardiac functional reserve as measured by exercise capacity is reduced in ApoE-/- mice (Niebauer et al. 1999), and we have shown that ApoE-/- mice have increased aortic and mitral flow velocity and increased heart-weight/body-weight ratio (HW/BW) consistent with volume overload hypertrophy (Hartley et al. 2000). It is unclear whether the observed decrease in H/B in ApoE-/- mice was a result of the presence of coronary lesions, restricting hyperemic flow or the increased baseline cardiac work, increasing resting flow.

Transverse aortic banding induces pressure overload cardiac hypertrophy in mice and is used to stress normal, old and genetically altered mice to study cardiac function and remodeling (Rockman et al 1993, Li et al 2003, Brickson et al 2006, Barrick et al 2007). Banded mice have significantly elevated HW/BW after one to five weeks, some show signs of heart failure and many die within three to five weeks after banding (Barrick et al. 2007). In dogs with pressure overload cardiac hypertrophy, it has been shown that CFR is reduced and that the subendocardium becomes more seriously underperfused and dysfunctional (Hittinger et al 1989, Vatner and Hittinger 1993, Duncker et al 1998, Hittinger et al 1995, Bache et al 1987). We hypothesized that mice would have lower CFR as estimated by H/B after banding, but before the development of symptomatic heart failure. We report here results from 10 mice showing that H/B is progressively decreased and essentially eliminated 21 d after transverse aortic banding. We also observed a significant and progressive increase in the systolic component of coronary flow following aortic banding, suggesting a redistribution of flow away from the subendocardium.

Section snippets

Animal protocol

This investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85 to 23, revised 1996). Ten C57BL/6 mice were studied following a protocol approved by the Institutional Animal Care and Use Committee of Baylor College of Medicine. For noninvasive measurements (including before banding), mice were anesthetized in a closed chamber with 3% isoflurane in oxygen for 2 to 5 min until immobile. Each mouse was

Results

Of the 10 mice studied, one died between day 1 and day 7 and another between day 14 and day 21, leaving eight mice alive at 21 d. Heart-weight/body-weight ratio (HW/BW) after 21 d was 8.30 ± 0.43 mg/g. Adequate signals were obtained from all live animals at all time points. Although the mean and standard error include data from all mice alive at the time, the p values from paired t-tests only include mice which were common to the two groups being compared.

Characteristics of the banded model

We have shown previously that transverse aortic banding in mice produces peripheral vascular adaptations and alterations including differential changes in velocities, waveforms and diameters of the right and left carotid arteries after 7 d, but that cardiac function as indicated by aortic and mitral velocities is maintained despite a significant increase in HW/BW (Li et al. 2003). We have also shown (Li et al. 2003) that the pressure drop across the aortic stenosis during systole can be

Conclusions

We show for the first time the serial and repeated measurement of coronary flow velocity in mice. The use of isoflurane gas at low and high concentrations as a coronary vasodilator when coupled with a method such as Doppler ultrasound to measure left main coronary flow or velocity provides a convenient and noninvasive method to estimate global coronary flow reserve in mice. Coronary flow reserve is reduced progressively and is virtually eliminated 21 d after transverse aortic banding primarily

Acknowledgments

We acknowledge the contributions of Thuy Pham, Jennifer Pocius and James Brooks for technical, surgical and editorial assistance. This work was supported in part by National Institutes of Health Grants R01-HL22512, P01-HL42550, R01-AG17899, R41-HL76928, and K25-HL73041.

References (49)

  • S. Brickson et al.

    In vivo left ventricular function capacity is compromised in cMyBP-C null mice

    Am J Physiol Heart Circ Physiol

    (2006)
  • J.S. Cole et al.

    The pulsed Doppler coronary artery catheter: Preliminary report of a new technique for measuring rapid changes in coronary artery flow velocity in man

    Circulation

    (1977)
  • G.J. Crystal

    Vasomotor effects of isoflurane in the coronary circulation

    Anesthesiology

    (1996)
  • G.J. Crystal et al.

    Coronary vasodilation by isoflurane: Abrupt versus gradual administration

    Anesthesiology

    (1995)
  • D.J. Duncker et al.

    Effect of treadmill exercise on transmural distribution of blood flow in hypertrophied left ventricle

    Am J Physiol Heart Circ Physiol

    (1998)
  • F.R. Eberli et al.

    Coronary reserve in patients with aortic valve disease before and after successful aortic valve replacement

    Eur Heart J

    (1989)
  • E.L. Fallen et al.

    Mechanisms of angina in aortic stenosis

    Circulation

    (1967)
  • A.K. Gamperi et al.

    Isoflurane-induced dilation of porcine coronary microvesels is endothelium dependent and inhibited by glibenclamide

    Anesthesiology

    (2002)
  • L.K. Gould et al.

    Physiologic basis for assessing critical coronary stenosis: Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve

    Am J Cardiol

    (1974)
  • J.R. Guyton et al.

    Flow restriction of one carotid artery in juvenile rats inhibits growth of arterial diameter

    Am J Physiol Heart Circ Physiol

    (1985)
  • H. Hamawaki et al.

    Pressure-overload hypertrophy is unabated in mice devoid of AT1A receptors

    Am J Physiol Heart Circ Physiol

    (1998)
  • C.J. Hartley et al.

    Hemodynamic changes in apolipoprotein E-knockout mice

    Am J Physiol Heart Circ Physiol

    (2000)
  • C.J. Hartley et al.

    Noninvasive cardiovascular phenotyping in mice

    ILAR J

    (2002)
  • L. Hatle et al.

    Noninvasive assessment of pressure drop in mitral stenosis by Doppler ultrasound

    Br Heart J

    (1978)
  • Cited by (45)

    • Evaluation of bi-ventricular coronary flow patterns using high-frequency ultrasound in mice with transverse aortic constriction

      2013, Ultrasound in Medicine and Biology
      Citation Excerpt :

      With the progress of the diseases, the hypertrophic left ventricle, with compromised function at the beginning, will eventually develop a decompensated condition with congestive heart failure (Lygate et al. 2007). It is thought that heart failure ensues only after the CFR is exhausted (Hartley et al. 2008). Therefore, the coronary arterial perfusion has been intensively studied and the CFR is commonly measured from the LCA using Doppler echocardiography (Gan et al. 2004; Graziosi et al. 2007; Hartley et al. 2008; Meimoun and Tribouilloy 2008; Wikström et al. 2005).

    • Assessment of spectral doppler in preclinical ultrasound using a small-size rotating phantom

      2013, Ultrasound in Medicine and Biology
      Citation Excerpt :

      Measurement of blood velocity is performed using the Doppler effect, both in the microcirculation and in major arteries (Christopher et al. 1997; Goertz et al. 2003). Blood velocity has been used as a surrogate for volumetric flow (Bonnin et al. 2008; Hartley et al. 2008; Ishikawa et al. 2003; Li et al. 2008) and for estimation of the degree of stenosis in models of atherosclerosis (Ni et al. 2008). Although there has been consideration of velocity measurement errors in clinical ultrasound, there is a lack of information on preclinical ultrasound systems.

    View all citing articles on Scopus
    View full text